The Company is basically a repository of the intellectual property rights on one single product, Ondrox. It was organized in 1994, specifically to acquire the control of LifeScience Corporation, Texas, which is the original beneficiary of the IP for Ondrox. Current total assets of the Company is in excess of $7 million.

The Company finally succeeded in acquiring control of LifeScience Corporation and its IP rights for Ondrox, for a price in the seven digits range in 1995 from the University of Texas, M. D. Anderson Cancer Center based in Houston, Texas, which remains a 10% shareholder in LifeScience Corporation.

Research on the product was done in the laboratories of M. D. Anderson Cancer Center, which is rated No.1 by U. S. News& World Report. In 2002, the U. S. Patent Office granted the patent which in its Abstract claims that it is protective against cancer and cardio vascular disease, as well as helps improve immunity and increase longevity. Based on tests performed on animals.

It is also the only antioxidant formulation that is endorsed by the National Foundation for Cancer Research, Washington, D. C.


The Company outsources all of its operational functions to third parties. These include manufacturing, distribution, call center, fulfillment services and accounting.

Ondrox was also sold under private labels by other companies including The Sharper Image. Sales are also conducted by partners in Korea and China.

The principal of LSI America Corporation, David K. G. Chan, is a well known business man who is also Chairman Emeritus of the Texas Asian Chamber of Commerce, as well as CEO of many corporations. These include a company in Africa that was used by Harvard Business School as a case study(Ejura Farms Ghana Ltd. ) and another that was named "Manufacturer of the Year 1992" located in Austin(Austin Concstuction Steel). He is also Chairman of Advisory Board of Jtec, Inc. A California company engaged in enterprise management software application, and is used to manage the construction projects of Olympic 2008 in China.

LSI America Corporation is indirectly owned by the Asia Development Trust, based in Anguilla. The beneficiary of the Trust is David K. G. Chan's family. Sister companies of the Trust are engaged in deal making and project development in several countries in Asia, including Nepal and China.

Products :
Patented antioxidant formulation developed by n0.1 cancer center in the u. S. Designed to protect against cancer, improve immunity and protect against cardio-vascular diseases and increase longevity

Moscow-based company renders services for manufacturers of pharmaceutical and biotechnological products, diagnostics, active substances, food supplements, medical equipment and devices providing penetration of our partner output in Russian market.
The company consists of the professionals having wide experience in medical and pharmaceutical business. The network of medical and sales representatives in the main regions of Russia allows us to cooperate successfully with general practitioners, medical officers and pharmacists, opinion-leaders in the field of medicine and pharmacy, wholesalers and retailers.
The adjusted contacts with various departments of Ministry of Health and Social Development of the Russian Federation as well as with regional health authorities enable us to solve the tasks of promotion of pharmaceutical and medical products at administrative level.
Our potential in the fields of marketing, registration and certifications, sales and logistic organization allows us to realize various projects with maximum benefits and minimum risks for our partners.
Delegation of business management to RegArd ltd means for our clients the investment in their products without any expenses connected to creation of a representative infrastructure, hiring of employees, taxes and insurances payment in Russia. Such kind of cooperation provides the foreign companies an unlimited access to Russian market in resource saving manner.

Products :
Market Authorization, A&P, Distributon And Sales In Russian Pharmaceutical Market

We, Pet-SOS. Com are located at South of Japan, supply thrombolytic enzyme, Lumbrokinaze -containing, for animals.

Lumbrokinaze is a fibrinolytic (fibrin-dissolving) enzyme which dissolves inert fibrin, the cause of blood clots. It was founded by Dr. Hisashi Mihara, Professors emeritus of Miyazaki Medical College, and he presented his study at the International Society & Thrombosis and Hemostasis Conference in Stockholm in 1983.

Lumbrokinaze is the plasmin that directly dissolves only fibrin, which causes thrombus. Without harming the veins, Lumbrokinaze is effective in diseases caused by thrombus such as myocardial infarction, diabetes, cerebral infarction, heart disease and high blood pressure. Lumbrokinaze is the first oral thrombolytic enzyme in the world.

Originally, Lumbrokinase-containing supplement has been developed for human, and it became very popular in Japan. Then, we developed for animals, it has been used at animal hospitals in Japan. Veterinarians use the supplement to treat dogs and cats with lifestyle diseases -- just like humans -- such as heart disease, diabetes, dementia, and cataracts.
Many veterinaries show surprise at its effectiveness.

We hope the supplement will help improvement of animal diseases all over countries.


Products :
Thrombolytic enzyme, thrombolytic enzyme supplement, Lubrokinase-containing supplement

Now we search for suppliers of Inbulk Finished Drugs(Tablets, Liquid, Powder for injection, Capsules), on the long-term cooperation for deliveries to Russia. With hope for the further cooperation we represent our company.

BRIEF INFORMATION ABOUT OUR COMPANY: TRADE HOUSE PHARMA-HOLDING, is a global trading and manufacturing company, established in 1993, which specializes in marketing and sale of bulk drugs, drug intermediates for the pharmaceutical industry, biotechnology, cosmetic industry, as well as fine chemicals and agrochemical products.

Our company, also has its own manufacturing facility where we carry out our manufacturing projects. In recent years, Our company, has evolved into a strategic product marketer and in many cases, has become the sole supplier of high quality pharmaceutical raw materials in Russia and CIS. The backbone of our success is ability to provide fast, reliable service at competitive rates consistently and respect needs of our customers. We have alliances with a diverse group of companies in India and South Korea, which are based on mutual understanding of building long term stable.

MISSION STATEMENT: We are searching, testing, promoting the most modern medical preparations and complex methods of treatment in the fields of dermatology, obstetrics, gynecology, urology, virology, immunology and other perspective spheres. We are specialized in these segments of Russian market and are experienced in the promotion of our products; therefore we are exclusive representatives of our foreign partners in Russia.
THE OFFER FOR MANUFACTURERS: Now we search for suppliers of Inbulk Finished Drugs, on the long-term cooperation for deliveries to Russia. If we will be arranged with quality and the price we shall make registration in the Ministry of Public Health of Russia. The size of the market Russia very big, and the given goods is in great demand. Therefore we search for partners of the most interested in progress of products on the market of Russia in cooperation with our company. I ask you to give the most competitive price of on term FOB.
We hope to have a chance to communicate with you and wish to co-operate with you in future.

P. S. After receiving yours price-list we shall inform you quantity of our order for drugs interesting to us.


Products :
Drugs & Medications ,  Bio-technology Products ,  Pharmaceutical Chemicals ,  Enzyme (Ferment) Preparations

We are a Biotech company, which caters to specific needs of the Textile Processing, Poultry/Feed, Fermentation, and Baking Industries with state-of-the-art technology and quality.

At United Biochemicals, every product is backed by R&D and stringent quality control. Keeping in mind that each customer has unique and specific requirements, all systems at our facilities are designed giving a lot of scope for flexibility in operations and innovation in working. Production facilities at United Biochemicals are designed as per cGMP and include all equipments to deliver consistent and quality products.

We are a company managed by technocrats having more than two decades experience is division of the Ganesh Group of Companies, a 30 year old Group recognised and respected for the design and manufacturing capabilities, including New Product Developments and Innovative Solutions encompassing Petrochemical, Pharmaceutical, Lubricants, Healthcare, Food & Beverage industries.

Our multi-location manufacturing units have been serving various Industry segments for last 29 years on the strength of our core competence in indigenous and endless Research & Development to find quality and cost effective solutions related to Petrochemical Derivatives and Speciality Chemicals.

Our business has a strong domestic and global positioning in the operating product categories. Our aggressive approach has placed us to sell these products in almost 39 countries to the best of the customers.

Textile Enzymes
Desizers
Biopolishing
Biofading
Peroxide Killer

If you need any kind of assistance/information, request you to please feel free at the following address.

Products :
Enzymes, desizer, peroxide Killer